Loading...
Westlake Corp (WLK) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's recent financial performance has been weak, with significant declines in revenue, net income, and EPS. Insider selling has surged, and technical indicators are mixed, showing no clear upward momentum. While some analysts have raised price targets and maintained Buy ratings, the overall sentiment is cautious due to macroeconomic challenges and weak Q4 results. The options data also reflects bearish sentiment with high Put-Call Ratios. Given the investor's preference for long-term stability, it is better to hold off on investing in WLK until clearer positive catalysts emerge.
The technical indicators are mixed. The MACD histogram is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 56.854, showing no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the key pivot level of 99.458, suggesting resistance at higher levels. Support levels are at 93.258 and 89.428, while resistance levels are at 105.658 and 109.488.

Some analysts have raised price targets, with Citi and UBS projecting targets as high as $124 and $129, respectively. The company has potential for earnings growth in FY26 due to cost reductions, M&A contributions, and favorable commodity pricing dynamics.
The company reported a significant net loss of $549 million in Q4 2025, with revenue down 10.9% YoY and EPS declining by 8660%. Insider selling has surged by 49690.74% in the last month. Additionally, the CFO's retirement and plans for plant closures add uncertainty. Hedge funds remain neutral, and options data reflects bearish sentiment.
Westlake's Q4 2025 financials were weak, with revenue declining to $2.53 billion (-10.90% YoY), net income dropping to -$549 million (-7942.86% YoY), and EPS falling to -4.28 (-8660.00% YoY). Gross margin also dropped significantly to 2.13 (-79.81% YoY).
Analyst sentiment is mixed. While several analysts have raised price targets and maintained Buy ratings, others remain Neutral due to macroeconomic challenges and weak Q4 results. Notable upgrades include Citi's target of $124 and UBS's target of $129, while Mizuho downgraded the stock to Neutral citing bearish industry views.